Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund in the Health category. It has $31.54M in assets, an expense ratio of 0.50% and a 0.34% dividend yield. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
Assets under management
$31.54M
Expense ratio
0.50%
Category
Health
Dividend yield
0.34%
NAV
$42.88
Fund family
Franklin Templeton Investments
Exchange
BATS
Top holdings
The largest positions Franklin Genomic Advancements ETF reports, by weight.